This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

63% Of Diabetics Risk Serious Foot Problems By Wearing Wrong Sized Shoes

Posted: Friday, November 23, 2007

Only one in three adults with diabetes wears shoes that fit properly, exposing themselves to serious foot problems that could lead to amputation, a new British study shows. The researchers measured the feet and shoes of 100 adults with diabetes at a diabetes clinic.

Fenofibrate Protects Against Diabetic Retinopathy

Posted: Friday, November 23, 2007

Patients with type 2 diabetes given fenofibrate for lipid lowering required significantly less laser treatment for retinopathy, investigators reported.

Type 2s With A1c of 6.5% Benefit From Post-Meal Hyperglycemia Control With Nateglinide

Posted: Friday, November 23, 2007

There has always been the question as to whether tighter control, treating to normal A1cs In type 2 diabetic patients is beneficial. This study showed that even in Type 2s with good glycemic control, additional reduction of postprandial hyperglycemia with nateglinide prevents the progression of atherosclerosis.

Intensive Diabetes Therapy Reduces Risk of Peripheral Artery Disease

Posted: Friday, November 23, 2007

Compared to conventional treatment, intensive treatment of diabetes is associated with a reduced rate of peripheral arterial calcification, according to researchers.

DHA Lowers Triglycerides in Patients Taking Statins

Posted: Friday, November 23, 2007

Like the omega-3 fatty acid EPA, DHA also enhances the effectiveness of statin medication in patients with high blood lipids by lowering triglycerides by about 27%.

Rosiglitazone to Stay on US Market With New Warnings About MI

Posted: Friday, November 23, 2007

The FDA has decided to allow the diabetes drug rosiglitazone (Avandia, GlaxoSmithKline) to stay on the market with increased warnings about the risk of cardiovascular events, while further studies are conducted to investigate the issue. A myocardial infarction warning will be added to the black box warning.

More Black Children Dying From Diabetes

Posted: Friday, November 23, 2007

Black children with diabetes face a death rate twice as high as that for white children, new U.S. government research shows.

Hemoglobin A1c Levels Effective Screening Test for Diabetes

Posted: Friday, November 23, 2007

Measuring patients' glycosylated hemoglobin levels (A1C) could be used to screen for diabetes, according to California-based researchers. It was shown to be more effective then using fasting blood sugars.

Comorbidities Lead to Neglected Diabetes Self-Care

Posted: Friday, November 23, 2007

When patients with diabetes have severe comorbidities, they are likely to deal with them while neglecting glucose monitoring and other self-care tasks, according to a new study.

Ten Dollar Pedometer Decreases Blood Pressure and Weight

Posted: Friday, November 23, 2007

The use of a 10 dollar pedometer and a Web site that tracked physical activity levels proved to be powerful motivators for people with diabetes who participated in a recent walking study.